Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

Study ID
NCT01308086

Study type
Interventional

Study phase
Phase 3

Study status
Unknown status

Trial Acronym

Trial Summary

The purpose of this study is to compare whether a 3-month treatment is at least not inferior to a 6-month treatment (FOLFOX-4 6 vs. 12 cycles or XELOX 4 cycles vs. 8 cycles) in terms of RFS in patients with high risk stage II or stage III radically resected colon cancer.

More informations

Trial Starting Date

Oct 31,2010

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

2000